期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | EMBO REPORTS LetPub Score 9.0
50 ratings
Rate
Reputation 10.0 Influence 8.2 Speed 9.4 | ||||||||||||||||||||||||
期刊簡稱 | EMBO REP | ||||||||||||||||||||||||
ISSN | 1469-221X | ||||||||||||||||||||||||
E-ISSN | 1469-3178 | ||||||||||||||||||||||||
h-index | 164 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 1.50%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | http://embor.embopress.org/ | ||||||||||||||||||||||||
在線稿件提交 | http://embor.msubmit.net/cgi-bin/main.plex | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | Wiley-Blackwell | ||||||||||||||||||||||||
主題領域 | 生物 | ||||||||||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||||||
創刊年 | 2000 | ||||||||||||||||||||||||
每年文章數 | 250每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 54.55% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1469-221X%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 1 Month(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: About 50% | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 下一頁 末頁 (頁 | |
[EMBO REPORTS] 的評論 | 撰寫評論 |
作者: 四风丽苹 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-27 11:34:41 評論於 Returning to Zone One(0) 讚! | 四风丽苹 |
作者: Alexander Browne 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-05 13:15:39 評論於 How long did it take for you to receive the successful submission email?(0) 讚! | Alexander Browne |
作者: 桃花高驰 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-02 16:35:43 評論於 Review Speed: 3.0 | Submission Acceptance Rate: 25.0 Experience Sharing: Lucky to have one article accepted. Although the Impact Factor is not high, the quality of the journal is very good and the review process is very strict(0) 讚! | 桃花高驰 |
作者: 长安丝琦 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-18 12:34:33 評論於 The initial review process will take about 50 days, within two months(0) 讚! | 长安丝琦 |
作者: Jackson S2023 領域: 生物学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2023-09-05 20:54:47 評論於 The authoritative journal in the field of molecular biology has strict review process. The review team consists of industry experts, and the review comments are very professional and of high quality. Articles with a high workload are worth a try(60) 讚! | Jackson S2023 |
作者: 蒙德明知 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-18 19:47:22 評論於 Within one month(0) 讚! | 蒙德明知 |
作者: 风见婉君 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-24 18:08:57 評論於 The first trial will be completed in about a month(0) 讚! | 风见婉君 |
作者: 风见婉君 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-24 12:00:40 評論於 Fast delivery, within one week(0) 讚! | 风见婉君 |
作者: 四风丽苹 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-21 23:25:23 評論於 Within a week(0) 讚! | 四风丽苹 |
作者: 月河樱潼 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-21 08:42:14 評論於 Okay, thank you(0) 讚! | 月河樱潼 |
作者: 月河樱潼 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-07 16:22:08 評論於 Recently, there are teachers who have submitted to this journal. How long does the initial review usually take?(0) 讚! | 月河樱潼 |
作者: 蒙德明知 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-06 12:21:48 評論於 I really don't understand why this journal, which is quite good, has been categorized as level two(0) 讚! | 蒙德明知 |
作者: keyanxiaolj 領域: 生物学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2022-12-26 09:59:42 評論於 Old magazines, the reputation is still good. The review process is also very rigorous, unlike some inferior journals. What is puzzling is that a small CDD edited by a Chinese expert has become a first-tier journal, while this one has been kicked out of the first-tier. I can't understand it.(36) 讚! | keyanxiaolj |
作者: 指挥棒 領域: 生物学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2022-12-22 20:01:54 評論於 I don't know if the leaders of the country are aware of how excessively the Chinese Academy of Sciences uses the baton in its division. Supporting domestic journals is a good thing, but it shouldn't be done at the expense of pulling up seedlings to help them grow. It disregards the life and death of personnel without qualifications. This is also the way it is for the scientific research big shots. They randomly publish and it becomes a first-tier journal. Thumbs up!(0) 讚! | 指挥棒 |
作者: 指挥棒 領域: 生物学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2022-12-22 19:55:58 評論於 Typical of making a big deal out of trivial matters, replacing classic journals with domestic ones. But can the domestic journals be obtained by researchers with no qualifications? They are just taking advantage of leaders' lack of understanding in research and messing around, truly amazing!(0) 讚! | 指挥棒 |
作者: 指挥棒 領域: 生物学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2022-12-22 19:51:14 評論於 ?, kick out of the first division, kick out of the top, IJMS and other water journals are all top, is this how you use a baton?(32) 讚! | 指挥棒 |
作者: 方建 領域: 生物学 審稿時間: 1.0 month(s) 結果: 直接被接受 撰寫評論 |
2022-12-22 09:22:12 評論於 Currently, there is a paper in the second round of review, which has been resubmitted to a different journal after being rejected by a top-tier journal. The first round of review provided more than 20 comments, which were exceptionally strict. Does the classification system of the Chinese Academy of Sciences aim to eliminate good papers in favor of inferior ones?(28) 讚! | 方建 |
作者: 四风丽苹 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-19 11:39:41 評論於 Research focus: Experience sharing of stem cells: Haha, everyone don't submit anymore, as the latest version of the Chinese Academy of Sciences partition in 2022, this journal has been removed from the first tier. The authority is powerful!(0) 讚! | 四风丽苹 |
作者: 辉夜一莹 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-25 20:25:14 評論於 Review speed: 2.0 | Submission hit rate: 25.0 Emphasized research direction: Tumor sharing experience: EMBO reports The current editor-in-chief is Professor Bernd Pulverer, who previously served as the editor of Nature Cell Biology. The magazine tends to publish articles with conceptual advances, with an average time from submission to acceptance of around 8 months(0) 讚! | 辉夜一莹 |
作者: slientwo 領域: 生物学 審稿時間: 6.0 month(s) 結果: 直接被接受 撰寫評論 |
2022-10-18 12:19:05 評論於 EMBO Publishing House, the second-in-command, was established in 2000. Cell reports, under the umbrella of CELL, should be imitating the publishing concept of this magazine, with an extremely similar style. However, EMBO reports are more rigorous. Everyone can try submitting their articles, and if you get accepted after external review, you will have a profound experience. It mainly accepts articles related to molecular biology. The magazine is very good, but there are very few Chinese submissions. It is mainly favored by some researchers from Chinese institutes.(10) 讚! | slientwo |
作者: 弘致小姐姐 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-25 23:31:01 評論於 Are you going back for rework? How long has the rework been going on? What is the status like?(0) 讚! | 弘致小姐姐 |
作者: 平原如彤 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-04 11:15:46 評論於 How can I not receive the decision letter, the editor does not reply, what should I do(0) 讚! | 平原如彤 |
作者: 墟散伟博 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-01-14 21:28:55 評論於 How long did it take for you to receive the email after May 11th?(0) 讚! | 墟散伟博 |
作者: 火焰自明 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-01-07 19:13:47 評論於 How long does it take to revise and resubmit after a rejection? Was the initial review process positive?(0) 讚! | 火焰自明 |
作者: 维尔娜菲茨杰拉德 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 20:20:28 評論於 Do not submit to newly established magazines with rapidly increasing impact factors; do not submit to journals with fewer published articles; do not submit to journals in regions where academic research is not very developed. Safe journals are those published by larger publishing groups or high-impact factor journals(0) 讚! | 维尔娜菲茨杰拉德 |
首頁 上一頁 1 2 3 下一頁 末頁 (頁 |
Contact us